Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Rick, Nichols"'
Autor:
Vidyleison N. Camargos, Shannan L. Rossi, Terry L. Juelich, Jennifer K. Smith, Nikos Vasilakis, Alexander N. Freiberg, Rick Nichols, Joan Fusco
Publikováno v:
Viruses, Vol 16, Iss 8, p 1181 (2024)
Filoviruses, like the Marburg (MARV) and Ebola (EBOV) viruses, have caused outbreaks associated with significant hemorrhagic morbidity and high fatality rates. Vaccines offer one of the best countermeasures for fatal infection, but to date only the E
Externí odkaz:
https://doaj.org/article/23bf9238b7d9461dbf9827f9edc06cd4
Autor:
Wenguang Cao, Shihua He, Guodong Liu, Helene Schulz, Karla Emeterio, Michael Chan, Kevin Tierney, Kim Azaransky, Geoff Soule, Nikesh Tailor, Abdjeleel Salawudeen, Rick Nichols, Joan Fusco, David Safronetz, Logan Banadyga
Publikováno v:
npj Vaccines, Vol 8, Iss 1, Pp 1-9 (2023)
Abstract Recombinant vesicular stomatitis viruses (rVSVs) engineered to express heterologous viral glycoproteins have proven to be remarkably effective vaccines. Indeed, rVSV-EBOV, which expresses the Ebola virus (EBOV) glycoprotein, recently receive
Externí odkaz:
https://doaj.org/article/085daf7c13654dfeb1807e18d2a02067
Autor:
Wenjun Zhu, Guodong Liu, Wenguang Cao, Shihua He, Anders Leung, Ute Ströher, Michael J. Fairchild, Rick Nichols, Joseph Crowell, Joan Fusco, Logan Banadyga
Publikováno v:
Vaccines, Vol 10, Iss 7, p 1004 (2022)
Marburg virus (MARV) is a negative-sense, single-stranded RNA virus that belongs to the Filoviridae family. Despite having caused numerous outbreaks of severe hemorrhagic fever with high case fatality rates, there are still no clinically approved the
Externí odkaz:
https://doaj.org/article/754c6112c51146dcbd11087858918e5e
Autor:
Heiko Ilchmann, Nathaly Samy, Daniela Reichhardt, Darja Schmidt, Jacqueline D Powell, Thomas P H Meyer, Günter Silbernagl, Rick Nichols, Heinz Weidenthaler, Laurence De Moerlooze, Liddy Chen, Paul Chaplin
Publikováno v:
The Journal of Infectious Diseases. 227:1203-1213
Background Although modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccination is approved for smallpox and monkeypox prevention, immunological persistence and booster effects remain undescribed. Methods Participants naive to smallpox vaccination
Autor:
Wenguang Cao, Shihua He, Guodong Liu, Helene Schulz, Karla Emeterio, Michael Chan, Kevin Tierney, Kim Azaransky, Geoff Soule, Nikesh Tailor, Abdjeleel Salawudeen, Rick Nichols, Joan Fusco, David Safronetz, Logan Banadyga
Recombinant vesicular stomatitis viruses (rVSVs) engineered to express heterologous viral glycoproteins have proven to be remarkably effective vaccines. Indeed, rVSV-EBOV, which expresses the Ebola virus (EBOV) glycoprotein, recently received clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1711b7604f03371857710c1757bf83a6
https://doi.org/10.1101/2022.11.11.516195
https://doi.org/10.1101/2022.11.11.516195
Autor:
Heiko, Ilchmann, Nathaly, Samy, Daniela, Reichhardt, Darja, Schmidt, Jacqueline D, Powell, Thomas Ph, Meyer, Günter, Silbernagl, Rick, Nichols, Heinz, Weidenthaler, Laurence, De Moerlooze, Liddy, Chen, Paul, Chaplin
Publikováno v:
The Journal of infectious diseases.
Though Modified Vaccinia Ankara - Bavarian Nordic (MVA-BN®). vaccination is approved for smallpox and monkeypox prevention, immunological persistence and booster effects remain undescribed.Participants naïve to smallpox vaccination were randomized
Publikováno v:
Am J Trop Med Hyg
Gamma irradiation (GI) is included in the CDC guidance on inactivation procedures to render a group of select agents and toxins nonviable. The Ebola virus falls within this group because it potentially poses a severe threat to public health and safet
Autor:
Rick Nichols
Publikováno v:
Lead-free Soldering Process Development and Reliability
Autor:
Rebecca J. Grant-Klein, Sheri Dubey, Stephen B. Kennedy, Jakub K. Simon, Rick Nichols, Joseph M. Antonello
Publikováno v:
Vaccine. 38:4885-4891
The recombinant vesicular stomatitis virus - Zaire Ebola virus envelope glycoprotein (rVSVΔG-ZEBOV-GP) vaccine is a live recombinant vesicular stomatitis virus (VSV) where the VSV G protein is replaced with ZEBOV-GP. To better understand the immune
Autor:
Jason C. Martin, Matthew T. Onorato, Beth-Ann Coller, Kenneth Liu, Rituparna Das, V Study Team, Rick Nichols, Scott A. Halperin, Rebecca J. Grant-Klein, Jakub K. Simon, Frans A. Helmond
Publikováno v:
The Journal of Infectious Diseases
Background This double-blind study assessed immunogenicity, lot consistency, and safety of recombinant vesicular stomatitis virus-Zaire Ebola virus envelope glycoprotein vaccine (rVSVΔG-ZEBOV-GP). Methods Healthy adults (N = 1197) were randomized 2: